More Sex Reduces Risk of Early Menopause
Menopause timing could be adaptive in response to sexual behavior, investigators found.
Related Articles
Post-COVID-19 Musculoskeletal Pain Often Fulfills Fibromyalgia Criteria
Over 70% of participants with MSK pain after COVID-19 fulfilled ACR fibromyalgia criteria in new research.
IV Secukinumab Rapidly Improved Clinical Responses in Psoriatic Arthritis
Results from INVIGORATE-2 showed IV secukinumab led to improved clinical measures of PsA, with a similar safety profile to subcutaneous secukinumab.
Increased Dietary Vitamin C Intake May Help Reduce Gout Risk, Study Finds
The analysis of NHANES data revealed an inverse association between dietary vitamin C intake and gout risk.
Online Tool Developed to Improve Diagnostic Skills of Non-Dermatologists for Psoriasis
This online diagnostic tool’s implementation among study participants led to increased confidence in making diagnoses of chronic plaque psoriasis.
New Administration Options Approved for Bimekizumab for Psoriasis, PsA
The new administration options allow a single-injection option for patients that require a 320 mg dose.
Etanercept, Infliximab Biosimilars Not Linked to Greater Infection Risks
Patients with IBD or arthritis were not found to be at a significantly higher risk of serious infection with a biosimilar versus originator of the…
HCPLive – Clinical news for connected physicians
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care…
IL-17, IL-23 Inhibitors Show Fastest Times to Meaningful Clinical Response for Psoriasis
These data resulted from comparisons of the time to onset of action among various available systemic medications for those with plaque psoriasis.
FDA Approves Ustekinumab (STELARA) Biosimilar for Chronic Inflammatory Diseases
The ustekinumab biosimilar will be available in early 2025, with indications to treat psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
Stronger Safety Considerations Needed for Lumateprone Use, Especially for Women
Being female and having bipolar II disorder were independent risk factors for serious AEs in a new study.